Browsing Centre for Biochemical Pharmacology by Subject "Lipids"

Now showing items 1-4 of 4

    • Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction. 

      Fosshaug, LE; Colas, RA; Anstensrud, AK; Gregersen, I; Nymo, S; Sagen, EL; Michelsen, A; Vinge, LE; Øie, E; Gullestad, L (2019-08)
      BACKGROUND: Termination of acute inflammation is an active process orchestrated by lipid mediators (LM) derived from polyunsaturated fatty acids, referred to as specialized pro-resolving mediators (SPM). These mediators ...

    • Enzymatic studies with 3-oxa n-3 DPA. 

      Pangopoulos, MK; Nolsøe, JMN; Antonsen, SG; Colas, RA; Dalli, J; Aursnes, M; Stenstrøm, Y; Hansen, TV (Elsevier, 2020-02-08)
      Cyclooxygenase-2 and several lipoxygenases convert polyunsaturated fatty acids into a large variety of products. During inflammatory processes, these enzymes form several distinct families of specialized pro-resolving lipid ...

    • Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis. 

      Dalli, J; Colas, RA; Walker, ME; Serhan, CN (2018)
      Solid-phase extraction coupled with liquid chromatography tandem mass spectrometry provides a robust and sensitive approach for the identification and quantitation of specialized pro-resolving mediators (lipoxins, resolvins, ...

    • Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes. 

      Shivakoti, R; Dalli, J; Kadam, D; Gaikwad, S; Barthwal, M; Colas, RA; Mazzacuva, F; Lokhande, R; Dharmshale, S; Bharadwaj, R (Elsevier, 2019-11-11)
      Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize ...